Sestad contains secnidazole that is structurally related to the commonly used 5- nitroimidazoles. It is indicated in treatment of amoebiasis, urethritis and vaginitis.

Pack size Box of 4 tablets, 12 tablets.
Shelf-life 24 months
Composition Secnidazole
Dosage forms and strengths Film-coated tablet: 500 mg
Product code :



Intestinal and hepatic amoebiasis. Giardiasis. Urethritis, vaginitis caused by Trichomonas vaginalis. Vaginitis caused by anaerobic microorganisms.


Intestinal amoebiasis: Adults: 2 g, children: 30 mg/kg/day, taken as a single dose before meal, in only 1 day (for acute symptomatic amoebiasis) or for 3 days (for asymptomatic amoebiasis).

Hepatic amoebiasis: Taken as a single dose or divided into many times before meals for 5 days. Adults: 1.5 g/day, for 5 days, children: 30 mg/kg/day. In the period of the pyosis, the treatment with secnidazole must be combination with pyoid drainage.

Giardias: Children: 30 mg/kg/day taken as a single dose for only 1 day.

Urethritis, vaginitis caused by Trichomonas vaginalis and by anaerobic microorganism: Adults: 2 g, as a single dose before meal. The partner should be treated at the same time with a similar dose.


Sestad is orally administered.

Hypersensitivity to the derivatives of imidazole or any components of this drug

Common: Nausea, epigastric pain, metallic taste, glossitis, stomatitis. Urticaria. Moderate leukopenia, which is reversible on treatment discontinuation.

Do not take any alcoholic beverages during treatment with secnidazole.

Do not take patients with history of blood disorders, history of blood dyscrasia.

Secnidazole should not be administered during the pregnancy. Patients should stop breastfeeding during treatment.

Dizziness has been reported after using the derivatives of imidazole. Patients should be aware of how they react to drug before driving or operating machinery.